Margo Georgiadis, Flagship CEO-Partner and CEO of Montai Therapeutics, shares Montai’s journey from R&D company to drug development company and how its platform is marrying untapped chemistry and powerful biological pathways to make leaps in how we treat chronic disease. More from Flagship @ JPM2024 here.
Related Companies
- Montai Therapeutics Founded: 2019
